IDO2 and melanoma: Additionally, other biomarkers such as MITF (microphthalmia-associated transcription factor), IDO (indoleamine 2,3-dioxygenase), and MDM2 (mouse double minute 2 homolog) have shown promise in regulating melanoma cell behavior, offering potential avenues for targeted therapeutic strategies.